Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion type Assertion NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_head.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion description "[Twenty-three percent of patients with T-ALL and 46% of patients with precursor B-ALL were classified in the low-risk group (P =.01) and had a 5-year relapse-free survival (RFS) rate of 98% or greater.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_provenance.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion evidence source_evidence_literature NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_provenance.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion SIO_000772 12036866 NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_provenance.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion wasDerivedFrom befree-20140225 NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_provenance.
- NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_assertion wasGeneratedBy ECO_0000203 NP884106.RAp9yGgHb3z7NWCbKLmZbsHJSHHls0yduRBdjwa2iRTuY130_provenance.